Registro:

Referencias:

• Yarden, Y., Sliwkowski, M.X., Untangling the ErbB signalling network (2001) Nat. Rev. Mol. Cell Biol., 2, pp. 127-137
• Jorissen, R.N., Epidermal growth factor receptor: Mechanisms of activation and signalling (2003) Exp. Cell Res., 284, pp. 31-53
• Schlessinger, J., Ligand-induced, receptor-mediated dimerization and activation of EGF receptor (2002) Cell, 110, pp. 669-672
• Gadella Jr., T.W.J., Jovin, T.M., Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation (1995) J. Cell Biol., 129, pp. 1543-1558
• Moriki, T., Maruyama, H., Maruyama, I.N., Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain (2001) J. Mol. Biol., 311, pp. 1011-1026
• Sako, Y., Minoghchi, S., Yanagida, T., Single-molecule imaging of EGFR signalling on the surface of living cells (2000) Nat. Cell Biol., 2, pp. 168-172
• Hynes, N.E., Horsch, K., Olayioye, M.A., Badache, A., The ErbB receptor tyrosine family as signal integrators (2001) Endocr. Relat. Cancer, 8, pp. 151-159
• Jaiswal, J.K., Mattoussi, H., Mauro, J.M., Simon, S.M., Long-term multiple color imaging of live cells using quantum dot bioconjugates (2003) Nat. Biotechnol., 21, pp. 47-51
• Gulliford, T.J., Huang, G.C., Ouyang, X., Epstein, R.J., Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2 (1997) Oncogene, 15, pp. 2219-2223
• Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M., Hynes, N.E., ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases (1999) J. Biol. Chem., 274, pp. 17209-17218
• Cho, H.S., Leahy, D.J., Structure of the extracellular region of HER3 reveals an interdomain tether (2002) Science, 297, pp. 1330-1333
• Cho, H.S., Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (2003) Nature, 421, pp. 756-760
• Ferguson, K.M., EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization (2003) Mol. Cell, 11, pp. 507-517
• Garrett, T.P.J., The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors (2003) Mol. Cell, 11, pp. 495-505
• Ogiso, H., Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains (2002) Cell, 110, pp. 775-787
• Nagy, P., Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2 (2002) J. Cell Sci., 115, pp. 4251-4262
• Martin-Fernandez, M., Clarke, D.T., Tobin, M.J., Jones, S.V., Jones, G.R., Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling (2002) Biophys. J., 82, pp. 2415-2427
• Lidke, D.S., Imaging molecular interactions in cells by dynamic and static fluorescence anisotropy (rFLIM and emFRET) (2003) Biochem. Soc. Trans., 31, pp. 1020-1027
• Deb, T.B., Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF (2001) J. Biol. Chem., 276, pp. 15554-15560
• Mendrola, J.M., Berger, M.B., King, M.C., Lemmon, M.A., The single transmembrane domains of erbB receptors self-associate in cell membranes (2002) J. Biol. Chem., 277, pp. 4704-4712
• Graus-Porta, D., Beerli, R.R., Daly, J.M., Hynes, N.E., ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling (1997) EMBO J., 16, pp. 1647-1655
• Wang, Z., Zhang, L., Yeung, T.K., Chen, X., Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation (1999) Mol. Biol. Cell, 10, pp. 1621-1636
• Wilkinson, J.C., Staros, J.V., Effect of ErbB2 coexpression on the kinetic interactions of epidermal growth factor with its receptor in intact cells (2002) Biochemistry, 41, pp. 8-14
• Nagy, P., Arndt-Jovin, D., Jovin, T.M., Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells (2003) Exp. Cell Res., 285, pp. 39-49
• Bridges, A.J., Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor (1996) J. Med. Chem., 39, pp. 267-276
• Hasson VI, T., Myosin two distinct roles endocytosis (2003) J. Cell Sci., 116, pp. 3453-3461
• Small, J.V., Stradal, T., Vignal, E., Rottner, K., The lamellipodium: Where motility begins (2002) Trends Cell Biol., 12, pp. 112-120
• Sliwkowski, M.X., Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin (1994) J. Biol. Chem., 269, pp. 14661-14665
• Dahan, M., Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking (2003) Science, 302, pp. 442-445
• Brock, R., Hamelers, I.H., Jovin, T.M., Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor (1999) Cytometry, 35, pp. 353-362
• Zacharias, D.A., Violin, J.D., Newton, A.C., Tsien, R.Y., Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells (2002) Science, 296, pp. 913-916

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------